Tenecteplase in Wake-up Ischaemic Stroke Trial
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 600 participants.
Also called NCT03181360
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 600 participants
- Registry
-
NCT03181360 -
2014-000096-80
-
- Other papers using this trial's data
- Safety and efficacy of tenecteplase in patients with wake-up stroke assessed by non-contrast CT (TWIST): a multicentre, open-label, randomised controlled trial
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Denmark, Estonia, Finland, Latvia, Lithuania, New Zealand, Norway, Sweden, Switzerland, United Kingdom
- Registry status
- Unknown status
Technical summary
Registry record NCT03181360. Randomized; single masking; primary purpose treatment. Start 2017-06-12 (actual); primary completion 2021-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Tenecteplase in Wake-up Ischaemic Stroke Trial
- Acronym
- TWIST
- Condition
- Ischemic Stroke
- Condition
- Stroke, Acute
- Intervention (Drug)
- Tenecteplase
- Intervention (Other)
- Control
- Lead sponsor
- University Hospital of North Norway
- Collaborator
- UiT The Arctic University of Norway
- Collaborator
- The Royal Norwegian Ministry of Health
- Collaborator
- Norwegian Health Association
Record details
- Record id
cardio:ct-nct03181360- Content hash
fd837445a46cfb20ffae195f2dd82d6086feba1bccbe4bc1cfebf91f78efdd7b